These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 3333409

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Renal allograft survival in outbred mongrel dogs using rabbit anti-dog thymocyte serum in combination with immunosuppressive drug therapy with or without donor bone marrow.
    Mathews KA, Holmberg DL, Johnston K, Miller CM, Binnington AG, Maxie G, Atilola M, Smith G.
    Vet Surg; 1994; 23(5):347-57. PubMed ID: 7839592
    [Abstract] [Full Text] [Related]

  • 4. Alternate-day cyclosporine A and azathioprine in experimental dog renal allografts.
    Collier DS, Calne RY, De Curtins M, Thiru S, White DJ, Jamieson NV, Thick M, Barroso E.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1279-80. PubMed ID: 3274318
    [No Abstract] [Full Text] [Related]

  • 5. Kidney graft survival in transfused and nontransfused sibling beagle dogs.
    Finco DR, Rawlings CA, Barsanti JA, Crowell WA.
    Am J Vet Res; 1985 Nov; 46(11):2327-31. PubMed ID: 3907436
    [Abstract] [Full Text] [Related]

  • 6. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC, Johnson K, Richie R, Nylander W, McMahon Y, Niblack G, Green W, Morrissey J, Ynares C.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract] [Full Text] [Related]

  • 7. Infectious complications with the use of cyclosporine versus azathioprine after cadaveric kidney transplantation.
    Shaffer D, Hammer SM, Monaco AP.
    Am J Surg; 1987 Apr; 153(4):381-6. PubMed ID: 3105340
    [Abstract] [Full Text] [Related]

  • 8. Are blood transfusions beneficial in the cyclosporine era?
    Potter DE, Portale AA, Melzer JS, Feduska NJ, Garovoy MR, Husing RM, Salvatierra O.
    Pediatr Nephrol; 1991 Jan; 5(1):168-72. PubMed ID: 2025530
    [Abstract] [Full Text] [Related]

  • 9. Prolongation effect of a small dose of FK506, cyclosporine, or azathioprine on renal allografts in dogs treated with fractionated lymphoid irradiation and donor bone marrow cell infusion.
    Watanabe K, Yuge K, Sato K, Yamagishi K, Sonoda K, Masaki Y, Maruyama S, Takahara H, Matsubayashi T, Yago K.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1112-5. PubMed ID: 2468213
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.
    Leone MR, Alexander SR, Melvin T, Striegel J, Reller K, Norman DJ, Barry JM.
    J Urol; 1990 Sep; 144(3):721-3. PubMed ID: 2388336
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of chronic kidney allograft rejection by cyclosporine.
    Abbud-Filho M, Ramalho HJ, Barberato JB, Corrente JE, Zerati-Filho M, Verona CB, Martucci RC, Bezas AG.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1660-2. PubMed ID: 2652544
    [No Abstract] [Full Text] [Related]

  • 13. Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood.
    Moyer TP, Post GR, Sterioff S, Anderson CF.
    Mayo Clin Proc; 1988 Mar; 63(3):241-7. PubMed ID: 3278174
    [Abstract] [Full Text] [Related]

  • 14. Effect of cyclosporine on fresh and preserved orthotopic small bowel allografts.
    Toledo-Pereyra LH, Kaufmann RJ, Bergren CT.
    P R Health Sci J; 1987 Dec; 6(3):147-52. PubMed ID: 3438458
    [Abstract] [Full Text] [Related]

  • 15. Single-center analysis of impact of immunosuppressive therapy upon renal allograft survival in the black population.
    Van Buren DH, Richie RE, Nylander W, Helderman H, MacDonell RC, Johnson HK.
    South Med J; 1991 Jun; 84(6):715-8. PubMed ID: 2052958
    [Abstract] [Full Text] [Related]

  • 16. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
    Kerman RH, Van Buren CT, Lewis RM, Kahan BD.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunosuppression with cyclosporine. A new approach to improve patency of venous allografts.
    Bandlien KO, Toledo-Pereyra LH, MacKenzie GH, Choudhury SP, Cortez JA.
    Arch Surg; 1983 Jul; 118(7):829-33. PubMed ID: 6860131
    [Abstract] [Full Text] [Related]

  • 20. Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression.
    Sutherland DE, Fryd DS, Strand M, Ascher N, Simmons RL, Najarian JS.
    Transplant Proc; 1984 Jun; 16(3):629-32. PubMed ID: 6375030
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.